Cure4 Cystic Fibrosis Foundation (C4CF) is excited to announce its new partnership with the National Foundation for Medical Research and Innovation (NFMRI).
NFMRI, who receive advice and recommendations from an established Research Advisory Committee, will manage and administer grants on behalf of Cure4 Cystic Fibrosis. Its role is to identify, evaluate and support innovative and high-quality research projects with a clear impact.
Beginning in early 2019, Cure4 Cystic Fibrosis will expand its grant program to the national scientific research community and offer grant funding opportunities to a competitive research market, Australia wide. The broad reach of the NFMRI grant program to universities and medical research institutes across Australia, means that Cure4 Cystic Fibrosis can be aware of and potentially fund the best CF research initiatives across the country.
Our scope is to fund research that seeks to develop therapies or cures that will result in an increase in average life expectancy of people with cystic fibrosis with consideration given to quality of life.
Expressions of interest will be called in three key gap areas known as social investment portfolios. Each of these portfolios supports research that falls within these gaps to help translate innovations through to next stages, so they may ultimately reach the community. For more information about the portfolio’s please visit https://nfmri.org.au/research-and-innovation/portfolio-summary/
Through collaboration with our CF community and investment in research we will help strengthen and expediate the delivery of research outcomes, which is ultimately a cure and treatments for all people living with CF.